A trade group representing compounding pharmacies has filed a lawsuit against the Food and Drug Administration (FDA) for ...

People who have depended on off-brand versions of Wegovy and Ozempic will likely have to pay more now that a nationwide ...

Hims & Hers is stopping its sales of an alternative to blockbuster weight-loss drugs Wegovy and Ozempic. That follows the U.S ...

The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded ...

This will be a “pivotal year,” one expert says, for GLP-1 drugs, which are massively disrupting the benefits landscape.

Makers of copycat weight-loss drugs and digital health companies that sell them are bracing for upheaval now that the Food ...

The Trump administration, perhaps surprisingly, chose to defend the legality of the Inflation Reduction Act’s (IRA’s) drug ...

The automakers are using software and AI to make vehicles of tomorrow more collaborative, working alongside passengers. The Singapore-based company expects to raise $2.58 billion from the sale of its ...

Eli Lilly (LLY) and Novo Nordisk (NVO) to dominate as TD Cowen lifts 2030 sales forecast for GLP-1 class of obesity/ diabetes ...

Trump’s tariff warning has created shockwaves through India’s pharmaceutical industry, which supplied almost half of ...

A JetBlue pilot from Ohio was arrested at Logan International Airport in Boston Thursday night before he was scheduled to ...

Home care workers aren't getting an increase in their pay under Governor JB Pritzker's proposed budget. Rachel Maddow breaks ...